Large-scale testing (Phase 3)Study completedNCT02879682What this trial is testingNTMS for Motor Mapping of Rolandic LesionsWho this might be right forGliomaBrain Metastases Technical University of Munich 330
Testing effectiveness (Phase 2)Ended earlyNCT04434560What this trial is testingNeoadjuvant Immunotherapy in Brain MetastasesWho this might be right forBrain Metastases, Adult Sarah Sammons, MD 1
Testing effectiveness (Phase 2)Study completedNCT00814021What this trial is testingSunitinib in Treating Patients With Kidney Cancer That Has Spread to the BrainWho this might be right forKidney CancerMetastatic Cancer Institut Claudius Regaud 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT03508752What this trial is testingNeurocognitive Decline in Patients With Brain MetastasesWho this might be right forBrain Metastases University of Texas Southwestern Medical Center 80
Testing effectiveness (Phase 2)Study completedNCT01578668What this trial is testingErlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain MetastasesWho this might be right forLung AdenocarcinomaBrain Metastases Guangzhou Medical University 69
Large-scale testing (Phase 3)UnknownNCT04870190What this trial is testingAlmonertinib Versus Osimertinib in the Patients With EGFR Mutations in Advanced NSCLC With Brain MetastasesWho this might be right forNSCLC Shanghai Chest Hospital 232
Testing effectiveness (Phase 2)Study completedNCT04967417What this trial is testingPembrolizumab With Standard Cytotoxic Chemotherapy in Treatment Naive NSCLC Patients With Asymptomatic Brain MetastasesWho this might be right forNon-small Cell Lung Cancer Samsung Medical Center 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT05256290What this trial is testingPhase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR MutationsWho this might be right forNon-Small Cell Lung CancerAdvanced Non-Small Cell Squamous Lung CancerMetastatic Lung Non-Small Cell Carcinoma+7 more Black Diamond Therapeutics, Inc. 200
Testing effectiveness (Phase 2)Study completedNCT01173497What this trial is testingA Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain MetastasisWho this might be right forEstrogen Receptor Negative (ER-Negative) Breast CancerProgesterone Receptor Negative (PR-Negative) Breast CancerHuman Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast Cancer+1 more Sanofi 44
Very early researchStudy completedNCT05704933What this trial is testingPilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain MetastasesWho this might be right forMetastatic MelanomaMetastasis to Brain H. Lee Moffitt Cancer Center and Research Institute 1
Not applicableUnknownNCT04397978What this trial is testingLocal Ablative Therapy for Patients With Multiple (4-10) Brain MetastasesWho this might be right forBrain Metastases, Adult Universitaire Ziekenhuizen KU Leuven 180
Not applicableStudy completedNCT04545814What this trial is testingAnalyzing Preoperative Stereotactic Radiosurgery With Gamma Knife Icon for Brain MetastasesWho this might be right forBrain Metastases Medical College of Wisconsin 11
Early research (Phase 1)Looking for participantsNCT04689048What this trial is testingAssess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic RadiosurgeryWho this might be right forBrain Metastases, AdultBrain MetastasesBrain Cancer Baptist Health South Florida 20
Early research (Phase 1)Study completedNCT01234740What this trial is testingBafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain MetastasesWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+7 more City of Hope Medical Center 7
Not applicableUnknownNCT05737589What this trial is testingCirculating Tumor DNA and T Cell Repertoire Predict Radiotherapeutic Outcomes in NSCLC Patients With Brain MetastasisWho this might be right forCarcinoma, Non-Small-Cell LungBrain Metastases Xiaorong Dong 50
Not applicableUnknownNCT05781633What this trial is testingThe Efficacy and Safety of Eutideron, Etoposide, and Bevacizumab in Patients With Brain Metastases From Breast Cancer.Who this might be right forMammary Neoplasms, Human Tianjin Medical University Cancer Institute and Hospital 43
Large-scale testing (Phase 3)Looking for participantsNCT06905587What this trial is testingMethylphenidate in Pediatric Brain Tumor Survivors With Cancer-related FatigueWho this might be right forBrain Tumor, PediatricCancer-related FatigueMethylphenidate Odense University Hospital 50
Early research (Phase 1)Study completedNCT00049023What this trial is testingRadiolabeled Octreotide in Treating Children With Advanced or Refractory Solid TumorsWho this might be right forBrain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more O'Dorisio, M S 27
Early research (Phase 1)Looking for participantsNCT06545682What this trial is testingPhase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)Who this might be right forMelanoma (Skin Cancer)Breast CancerBrain Metastasases M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT06839560What this trial is testingEvaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With VEX Metronomic Chemotherapy and Concurrent or Delayed Radiotherapy in Patients With Advanced HER2-Negative Breast Cancer With Brain MetastasisWho this might be right forBrain Metastasis From Advanced HER2-negative Breast Cancer Cancer Institute and Hospital, Chinese Academy of Medical Sciences 102